Research graph
References from A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
10.1016/j.chom.2020.04.004
10.1016/j.chom.2020.04.004 · External reference
10.1016/j.jviromet.2021.114221
10.1016/j.jviromet.2021.114221 · External reference
Human Coronavirus: Host-Pathogen Interaction
10.1146/annurev-micro-020518-115759 · 2019 · External reference
10.1016/j.antiviral.2014.06.013
10.1016/j.antiviral.2014.06.013 · External reference
10.1038/nrmicro2147
10.1038/nrmicro2147 · External reference
10.1099/vir.0.19424-0
10.1099/vir.0.19424-0 · External reference
10.1128/jvi.79.23.14909-14922.2005
10.1128/jvi.79.23.14909-14922.2005 · External reference
Neither the RNA nor the proteins of open reading frames 3a and 3b of the coronavirus infectious bronchitis virus are essential for replication
10.1128/jvi.80.1.296-305.2006 · 2006 · External reference
10.1002/jmv.25681
10.1002/jmv.25681 · External reference
10.1016/j.genrep.2020.100682
10.1016/j.genrep.2020.100682 · External reference
10.1038/s41580-021-00432-z
10.1038/s41580-021-00432-z · External reference
10.1016/s0065-3527(06)66005-3
10.1016/s0065-3527(06)66005-3 · External reference
10.1146/annurev-virology-100114-055218
10.1146/annurev-virology-100114-055218 · External reference
10.1016/j.molcel.2021.02.036
10.1016/j.molcel.2021.02.036 · External reference
Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection
10.1016/j.celrep.2021.109108 · 2021 · External reference
10.1016/j.molcel.2021.04.022
10.1016/j.molcel.2021.04.022 · External reference
Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription
10.1128/jvi.02011-09 · 2010 · External reference
10.1128/jvi.78.22.12683-12688.2004
10.1128/jvi.78.22.12683-12688.2004 · External reference
10.1016/j.jmb.2009.09.040
10.1016/j.jmb.2009.09.040 · External reference
10.1128/jvi.01331-15
10.1128/jvi.01331-15 · External reference
10.1073/pnas.97.10.5516
10.1073/pnas.97.10.5516 · External reference
10.1128/jvi.00385-06
10.1128/jvi.00385-06 · External reference
Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone
10.1128/jvi.80.7.3670-3674.2006 · 2006 · External reference
Coronavirus reverse genetic systems: infectious clones and replicons
10.1016/j.virusres.2014.05.026 · 2014 · External reference
Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector
10.1073/pnas.89.18.8794 · 1992 · External reference
10.3390/vaccines7020037
10.3390/vaccines7020037 · External reference
10.3390/v8050122
10.3390/v8050122 · External reference
Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents
10.1128/aac.44.6.1588-1597.2000 · 2000 · External reference
Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomes
10.4161/cc.10.3.14708 · 2011 · External reference
Use of bacterial artificial chromosomes in baculovirus research and recombinant protein expression: current trends and future perspectives
2012 · External reference
Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2
10.1007/s13238-021-00832-z · 2021 · External reference
The 2019 novel coronavirus resource
2020 · External reference
10.1016/j.febslet.2004.09.009
10.1016/j.febslet.2004.09.009 · External reference
The establishment of reference sequence for SARS-CoV-2 and variation analysis
10.1002/jmv.25762 · 2020 · External reference
10.1128/jvi.79.9.5288-5295.2005
10.1128/jvi.79.9.5288-5295.2005 · External reference
10.1099/0022-1317-82-2-385
10.1099/0022-1317-82-2-385 · External reference
10.1016/j.cell.2020.04.011
10.1016/j.cell.2020.04.011 · External reference
Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids
10.1016/j.ijbiomac.2022.01.121 · 2022 · External reference
10.1371/journal.ppat.1009100
10.1371/journal.ppat.1009100 · External reference
Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle
10.1128/jvi.01925-19 · 2020 · External reference
10.3390/v13061115
10.3390/v13061115 · External reference
Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak
10.1016/j.compbiolchem.2021.107533 · 2021 · External reference
Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism
10.1016/j.virusres.2021.198401 · 2021 · External reference
Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein
10.1016/j.compbiolchem.2021.107594 · 2021 · External reference
10.1016/j.genrep.2022.101608
10.1016/j.genrep.2022.101608 · External reference
10.1074/jbc.m805747200
10.1074/jbc.m805747200 · External reference
10.1016/j.chom.2014.09.009
10.1016/j.chom.2014.09.009 · External reference
10.1139/w08-139
10.1139/w08-139 · External reference
10.1111/j.1742-4658.2008.06564.x
10.1111/j.1742-4658.2008.06564.x · External reference
10.1371/journal.ppat.1009439
10.1371/journal.ppat.1009439 · External reference
10.1038/s41422-020-0282-0
10.1038/s41422-020-0282-0 · External reference
Unresolved reference
External reference
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
10.1038/s41421-020-0156-0 · 2020 · External reference
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
2021 · External reference
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
10.1038/s41598-021-82055-0 · 2021 · External reference
10.1016/j.virol.2006.10.016
10.1016/j.virol.2006.10.016 · External reference
